Genetic Risk, Lifestyle Predict CVD, Diabetes Independently
No interactions seen for any outcome; log-additive effect on risk of developing cardiovascular disease
Enzalutamide Improves Outcomes for Aggressive Prostate Cancer
Treatment led to 71 percent lower risk of metastasis or death compared to placebo
Health Care Technology Impacts Younger Patient Satisfaction
Younger health care consumers are dissatisfied with technology capability of health care organizations
USPSTF Favors Osteoporosis Screening to Prevent Fracture
Screening with bone measurement recommended for women aged ≥65, younger women at risk
Combination of LABA + Inhaled Glucocorticoid Safe in Asthma
Also results in significantly fewer asthma exacerbations than inhaled glucocorticoid alone
Half of CV Events Occur from Two to Five Years Post-TIA, -Stroke
Composite outcome occurred in 12.9 percent; 50.1 percent of events in second to fifth years
Azithromycin Cuts Pulmonary Exacerbation in CF With Early Pa
Risk of pulmonary exacerbation down for children with cystic fibrosis, early Pseudomonas aeruginosa
Few Hemodialysis Patients on Medicare Enroll in Hospice
Patterns of use, timing of hospice similar among patients with diverse spending trajectories
Binge Drinking Linked to Increased Systolic BP in Men
And relative risk for hypertension up with any drinking among men without hypertension
Most Bleeding Events in Non-CVD Patients Are GI-Related
In cohort with no CVD, not receiving antiplatelet therapy, 7 percent of bleeding events were fatal